Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Med.

Sec. Rheumatology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1625915

This article is part of the Research TopicSarcoidosis Diagnosis and Treatment Based on EtiologyView all 8 articles

Review (2 nd manuscript for the special issue in Frontier in Medicine) Latent Microbial Reactivation and Immune Dysregulation in Sarcoidosis: Bridging pathogenesis and Precision Therapeutics

Provisionally accepted
Michiru  SawahataMichiru Sawahata1Keisuke  UchidaKeisuke Uchida2Asuka  FurukawaAsuka Furukawa2Yoshinobu  EishiYoshinobu Eishi2*Makoto  MaemondoMakoto Maemondo1,1
  • 1Jichi Medical University, Tochigi, Japan
  • 2Institute of Science Tokyo Hospital, Tokyo, Japan

The final, formatted version of the article will be published soon.

Sarcoidosis, a systemic granulomatous disease of unknown etiology, is characterized by the formation of non-caseating granulomas affecting multiple organs. Accumulating evidence implicates Cutibacterium acnes (C. acnes; formerly Propionibacterium acnes) as a potential microbial trigger. The consistent detection of C. acnes within sarcoid granulomas, along with associated Th1-polarized immune responses, indicates that latent intracellular persistence and reactivation of this commensal bacterium may drive granulomatous inflammation. This bacterium can persist intracellularly within macrophages and dendritic cells and, upon reactivation, may induce Th1/Th17-dominant immune responses in genetically and immunologically susceptible individuals. Immune dysregulation, including deficient C. acnesspecific regulatory T cell (Treg) responses, may underlie the unchecked effector activity that sustains inflammation. Enhanced C. acnes-specific T-cell reactivity, including elevated interferon-γ and interleukin-2 production, is observed in some patients, supporting this hypothesis. Although direct evidence for C. acnes-specific Tregs and antigen-specific T-cell responses is limited, immune dysregulation involving impaired tolerance is thought to contribute to the heterogeneity of sarcoidosis, which ranges from spontaneous remission to chronic fibrotic progression. Recent advances in diagnostic tools, including P. acnes-specific monoclonal antibody immunostaining and T-cell assays specific to C. acnes, offer promising approaches for detecting microbial involvement. These developments highlight the importance of etiologydriven treatment strategies. As sarcoidosis likely comprises a spectrum of underlying causes, etiology-specific interventions are particularly warranted upon the identification of a defined trigger, such as C. acnes. This review explores the potential pathogenesis of sarcoidosis, focusing on latent microbial reactivation, immune dysregulation, and their diagnostic and therapeutic implications, and highlights opportunities for precision medicine.

Keywords: Sarcoidosis, Cutibacterium acnes, Latent intracellular infection, Reactivation, Regulatory T-lymphocytes, Immune Tolerance, Granulomatous inflammation, precision medicine

Received: 09 May 2025; Accepted: 04 Aug 2025.

Copyright: © 2025 Sawahata, Uchida, Furukawa, Eishi and Maemondo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yoshinobu Eishi, Institute of Science Tokyo Hospital, Tokyo, Japan

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.